Checkpoint Inhibitor

Rosenberg JE, Galsky MD, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, van der Heijden MS, Dreicer R, Durán[...]

By sjmartinez • December 8, 2024

Alkassis S, Shatta M, Wong DJ. Therapeutic Advances in Advanced Basal Cell Carcinoma. Cancers (Basel). 2024 Sep 4;16(17):3075. doi: 10.3390/cancers16173075. PMID: 39272933; PMCID: PMC11394629.

By sjmartinez • September 15, 2024

Alkassis S, Fitzsimmons K, Hurvitz S. Pembrolizumab-induced nephrotoxicity in a patient with breast cancer. Ther Adv Med Oncol. 2024 Apr 25;16:17588359241248362. doi: 10.1177/17588359241248362. PMID: 38680292;[...]

By sjmartinez • April 29, 2024

Bikhchandani M, Amersi F, Hendifar A, Gangi A, Osipov A, Zaghiyan K, Atkins K, Cho M, Aguirre F, Hazelett D, Alvarez R, Zhou L, Hitchins[...]

By sjmartinez • May 28, 2023

Johnson ML, Strauss J, Patel MR, Garon EB, Eaton KD, Neskorik T, Morin J, Chao R, Halmos B. Mocetinostat in Combination With Durvalumab for Patients[...]

By sjmartinez • March 9, 2023

Talukder R, Makrakis D, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Jindal T, Koshkin VS, Park JJ,[...]

By sjmartinez • September 27, 2022